Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Frontiers in Immunology
|
January 25, 2021
CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis
Blagoje Soskic, Louisa E Jeffery, Alan Kennedy, et al.
Cell Reports
|
November 3, 2024
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy
Braxton L Jamison, Matthew Lawrance, Chun Jing Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 9, 2005
Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells
Karen I Mead, Yong Zheng, Claire N Manzotti, et al.
Frontiers in Immunology
|
December 28, 2020
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
Neil Halliday, Cayman Williams, Alan Kennedy, et al.
Cell Reports
|
September 15, 2024
Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interaction
Maximillian A Robinson, Alan Kennedy, Carolina T Orozco, et al.
The Journal of Biological Chemistry
|
January 21, 2012
Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation
Omar S Qureshi, Satdip Kaur, Tie Zheng Hou, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 26, 2008
Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity
Emily M Schmidt, Chun Jing Wang, Gemma A Ryan, et al.
Science Immunology
|
June 2, 2019
CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells
Vitalijs Ovcinnikovs, Ellen M Ross, Lina Petersone, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 24, 2023
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies
Brianna M Lax, Joseph R Palmeri, Emi A Lutz, et al.
The Journal of Clinical Investigation
|
December 9, 2014
Follicular helper T cell signature in type 1 diabetes
Rupert Kenefeck, Chun Jing Wang, Tauseef Kapadi, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Frontiers in Immunology
|
January 25, 2021
CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis
Blagoje Soskic, Louisa E Jeffery, Alan Kennedy, et al.
Cell Reports
|
November 3, 2024
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy
Braxton L Jamison, Matthew Lawrance, Chun Jing Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 9, 2005
Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells
Karen I Mead, Yong Zheng, Claire N Manzotti, et al.
Frontiers in Immunology
|
December 28, 2020
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
Neil Halliday, Cayman Williams, Alan Kennedy, et al.
Cell Reports
|
September 15, 2024
Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interaction
Maximillian A Robinson, Alan Kennedy, Carolina T Orozco, et al.
The Journal of Biological Chemistry
|
January 21, 2012
Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation
Omar S Qureshi, Satdip Kaur, Tie Zheng Hou, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 26, 2008
Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity
Emily M Schmidt, Chun Jing Wang, Gemma A Ryan, et al.
Science Immunology
|
June 2, 2019
CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells
Vitalijs Ovcinnikovs, Ellen M Ross, Lina Petersone, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 24, 2023
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies
Brianna M Lax, Joseph R Palmeri, Emi A Lutz, et al.
The Journal of Clinical Investigation
|
December 9, 2014
Follicular helper T cell signature in type 1 diabetes
Rupert Kenefeck, Chun Jing Wang, Tauseef Kapadi, et al.
Page
of 7